<?xml version="1.0" encoding="UTF-8"?>
<funding-group>
 <award-group id="award001">
  <funding-source>
   <institution-wrap>
    <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000024</institution-id>
    <institution>Canadian Institutes of Health Research</institution>
   </institution-wrap>
  </funding-source>
  <award-id>THA-118569</award-id>
  <principal-award-recipient>
   <name>
    <surname>Brockman</surname>
    <given-names>Mark</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <funding-statement>This study was funded by the Canadian Institutes for Health Research and the Canadian HIV Vaccine Initiative grant number: THA-118569 to JD, JS, GG, TN, MB and AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
